Source: Cancer Research. Unidade: IQSC
Assunto: QUÍMICA
ABNT
ROBERGE, Michel et al. High-Throughput assay for 'G IND.2' checkpoint inhibitors and identification of the structurally novel compound isogranulatimide. Cancer Research, v. 58, p. 5701-5706, 1998Tradução . . Acesso em: 01 out. 2024.APA
Roberge, M., Berlinck, R. G. de S., Xu, L., Anderson, H. J., Lim, L. Y., Curman, D., et al. (1998). High-Throughput assay for 'G IND.2' checkpoint inhibitors and identification of the structurally novel compound isogranulatimide. Cancer Research, 58, 5701-5706.NLM
Roberge M, Berlinck RG de S, Xu L, Anderson HJ, Lim LY, Curman D, Stringer CM, Friend SH, Davies P, Vincent I, Haggarty SJ, Kelly MT, Britton R, Piers E, Andersen RJ. High-Throughput assay for 'G IND.2' checkpoint inhibitors and identification of the structurally novel compound isogranulatimide. Cancer Research. 1998 ;58 5701-5706.[citado 2024 out. 01 ]Vancouver
Roberge M, Berlinck RG de S, Xu L, Anderson HJ, Lim LY, Curman D, Stringer CM, Friend SH, Davies P, Vincent I, Haggarty SJ, Kelly MT, Britton R, Piers E, Andersen RJ. High-Throughput assay for 'G IND.2' checkpoint inhibitors and identification of the structurally novel compound isogranulatimide. Cancer Research. 1998 ;58 5701-5706.[citado 2024 out. 01 ]